(Q33735138)

29 July 2017

title

Interpretive standards for disk susceptibility tests with Sch 21420 and amikacin (English)

1 reference

29 July 2017

1 reference

1

Barry AL

1 reference

29 July 2017

2

Thornsberry C

1 reference

29 July 2017

4

Gerlach EH

1 reference

29 July 2017

Jones RN

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 October 1980

1 reference

Antimicrobial Agents and Chemotherapy

29 July 2017

published in

1 reference

29 July 2017

volume

18

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

616-621

1 reference

Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284059

Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284059

Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284059

In vitro studies with Sch 21420 and Sch 22591: activity in comparison with six other aminoglycosides and synergy with penicillin against enterococci

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284059

The syntheses and biological properties of 1-N-(S-4-amino-2-hydroxybutyryl)-gentamicin B and 1-N-(S-3-amino-2-hydroxypropionyl)-gentamicin B.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284059

Piperacillin susceptibility tests by the single-disk agar diffusion technique

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284059

Interpretation of the Disk Diffusion Susceptibility Test for Amikacin: Report of a Collaborative Study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284059

1-N HAPA gentamicin B,a new aminoglycoside active against gentamicin resistant isolates - activity compared to other aminoglycosides

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=284059

Biological activity of SCH 21420, the 1-N-S-alpha-hydroxy-beta-aminopropionyl derivative of gentamicin B

21 June 2018

1 reference

12 December 2020

Serum concentrations and inhibitory ratios during amikacin therapy of gram-negative infections

1 reference

12 December 2020

Comparative in vitro activity of a semisynthetic derivative of gentamicin B (SCH 21420) and five other aminoglycosides

1 reference

12 December 2020

Cefaclor and Cefatrizine, New Investigational Orally Administered Cephalosporins: ln-vitro Collaborative Evaluation Against Clinical Bacterial Isolates and Comparison with Related Antimicrobics

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.18.4.616

1 reference

29 July 2017

1 reference

29 July 2017

1 reference